breseq  version 0.33.1  revision 8505477f25b3 mutation predictions | marginal predictions | summary statistics | genome diff | command line log

Marginal read alignment evidence
	seq id	position		ref	new	freq	score (cons/poly)	reads	annotation	genes	product
*	REL606	3,492,082	0	T	G	50.0%	38.7 / 38.4	52	V490G (GTG→GGG)	glpD	sn‑glycerol‑3‑phosphate dehydrogenase, aerobic, FAD/NAD(P)‑binding
*	REL606	4,574,252	0	T	G	37.8%	47.0 / 24.0	37	S5S (TCA→TCC)	hpaX	hypothetical 4‑hydroxyphenylacetate permease
*	REL606	2,296,329	0	A	C	33.8%	134.3 / 51.6	77	intergenic (‑149/‑66)	inaA/yfaH	hypothetical protein/hypothetical protein
*	REL606	1,747,903	0	G	T	33.7%	205.7 / 99.8	104	A8S (GCA→TCA)	ydiL	hypothetical protein
*	REL606	1,875,483	0	G	C	31.3%	254.3 / 123.9	132	intergenic (+156/‑28)	yeaB/sdaA	predicted NUDIX hydrolase/L‑serine deaminase I
*	REL606	273,581	0	T	G	31.1%	152.6 / 12.1	74	G136G (GGT→GGG)	yagU	conserved inner membrane protein
*	REL606	3,983,700	0	T	G	29.6%	96.8 / 21.4	54	T397P (ACC→CCC)	ECB_03713	conserved hypothetical protein
*	REL606	2,631,772	0	A	C	28.6%	107.3 / 17.4	49	intergenic (‑267/‑141)	rpoE/nadB	RNA polymerase, sigma 24 (sigma E) factor/L‑aspartate oxidase
*	REL606	2,417,495	0	T	A	25.7%	188.8 / 20.2	70	L24F (TTA→TTT)	emrK	EmrKY‑TolC multidrug resistance efflux pump, membrane fusion protein component
*	REL606	1,688,990	0	A	C	21.7%	165.4 / 10.9	60	T92P (ACC→CCC)	nth	DNA glycosylase and apyrimidinic (AP) lyase (endonuclease III)